Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Dynavax Technologies (DVAX)

Dynavax Technologies (DVAX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
10.82 -0.08 (-0.73%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 10.82 unch (unch) 16:02 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
10.68
Day High
10.92
Open 10.81
Previous Close 10.90 10.90
Volume 1,508,100 1,508,100
Avg Vol 2,834,095 2,834,095
Stochastic %K 27.16% 27.16%
Weighted Alpha -9.91 -9.91
5-Day Change +0.51 (+4.95%) +0.51 (+4.95%)
52-Week Range 9.74 - 14.63 9.74 - 14.63
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,548,512
  • Shares Outstanding, K 122,412
  • Annual Sales, $ 277,250 K
  • Annual Income, $ 27,310 K
  • EBIT $ -4 M
  • EBITDA $ -11 M
  • 60-Month Beta 1.26
  • Price/Sales 4.78
  • Price/Cash Flow 68.33
  • Price/Book 2.38

Options Overview Details

View History
  • Implied Volatility 59.72% ( +14.61%)
  • Historical Volatility 45.76%
  • IV Percentile 88%
  • IV Rank 39.18%
  • IV High 134.84% on 04/07/25
  • IV Low 11.34% on 09/23/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 284
  • Volume Avg (30-Day) 408
  • Put/Call OI Ratio 1.22
  • Today's Open Interest 11,458
  • Open Int (30-Day) 9,189

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.03
  • Number of Estimates 2
  • High Estimate 0.03
  • Low Estimate 0.03
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +142.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.04 +7.77%
on 04/21/25
Period Open: 13.98
14.08 -23.15%
on 03/26/25
-3.16 (-22.60%)
since 03/25/25
3-Month
10.04 +7.77%
on 04/21/25
Period Open: 12.74
14.63 -26.04%
on 03/07/25
-1.92 (-15.07%)
since 01/24/25
52-Week
9.74 +11.09%
on 08/06/24
Period Open: 11.17
14.63 -26.04%
on 03/07/25
-0.35 (-3.13%)
since 04/25/24

Most Recent Stories

More News
AXSM Stock Down on Top-Line Data From Depression Study on Solriamfetol

Axsome Therapeutics AXSM announced top-line data from the phase III PARADIGM study, which evaluated solriamfetol for the treatment of major depressive disorder (MDD) with and without severe excessive daytime...

KRYS : 168.06 (-0.63%)
JAZZ : 110.80 (+1.67%)
DVAX : 10.82 (-0.73%)
AXSM : 106.27 (+0.82%)
BEAM's IND for BEAM-302 in Genetic Disorder Study Gets FDA Clearance

Beam Therapeutics Inc. BEAM announced that the FDA has cleared the investigational new drug (IND) application to begin clinical studies on its pipeline candidate, BEAM-302, for the treatment of alpha-1...

BEAM : 19.52 (-3.22%)
KRYS : 168.06 (-0.63%)
JAZZ : 110.80 (+1.67%)
DVAX : 10.82 (-0.73%)
Why Dynavax Technologies (DVAX) Stock Might be a Great Pick

One stock that might be an intriguing choice for investors right now is Dynavax Technologies Corporation DVAX. This is because this security in the Medical - Biomedical and Genetics space is seeing solid...

DVAX : 10.82 (-0.73%)
Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript

DVAX earnings call for the period ending December 31, 2024.

DVAX : 10.82 (-0.73%)
Dynavax Technologies: Q4 Earnings Snapshot

Dynavax Technologies: Q4 Earnings Snapshot

DVAX : 10.82 (-0.73%)
Implied Volatility Surging for Dynavax Technologies (DVAX) Stock Options

Investors in Dynavax Technologies Corporation DVAX need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $3 Call had some of the highest...

DVAX : 10.82 (-0.73%)
Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't?

Investors in Dynavax Technologies Corporation DVAX need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $03.00 Call had some of the highest...

DVAX : 10.82 (-0.73%)
Dynavax Technologies (DVAX) Q3 2024 Earnings Call Transcript

DVAX earnings call for the period ending September 30, 2024.

DVAX : 10.82 (-0.73%)
Dynavax Technologies: Q3 Earnings Snapshot

Dynavax Technologies: Q3 Earnings Snapshot

DVAX : 10.82 (-0.73%)
Dynavax Technologies (DVAX) Q2 2024 Earnings Call Transcript

DVAX earnings call for the period ending June 30, 2024.

DVAX : 10.82 (-0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development...

See More

Key Turning Points

3rd Resistance Point 11.16
2nd Resistance Point 11.04
1st Resistance Point 10.93
Last Price 10.82
1st Support Level 10.69
2nd Support Level 10.57
3rd Support Level 10.46

See More

52-Week High 14.63
Fibonacci 61.8% 12.76
Fibonacci 50% 12.18
Fibonacci 38.2% 11.61
Last Price 10.82
52-Week Low 9.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.